The goal of this project is to identify critical negative regulators of T cell activity in highly immunosuppressive tumor microenvironments. We have developed a highly novel approach that enables in vivo discovery of novel therapeutic targets using next generation sequencing technologies. The project involves mechanistic characterization of critical negative regulators and evaluation of their therapeutic potential for adoptive T cell therapies, including chimeric antigen receptors (CAR). Requirements are a recent PhD in immunology, cancer biology or molecular biology.
Please send CV and names/email addresses of three references to kai_wucherpfennig@dfci.harvard.edu.
Please visit our lab website for more information: http://research4.dfci.harvard.edu/tcell/
为防止简历投递丢失请抄送一份至：boshijob@126.com（邮件标题格式：应聘职位名称+姓名+学历+专业+中国博士人才网）
中国-博士人才网发布
声明提示：凡本网注明“来源：XXX”的文/图等稿件，本网转载出于传递更多信息及方便产业探讨之目的，并不意味着本站赞同其观点或证实其内容的真实性，文章内容仅供参考。
